Weekly exenatide PBS listed for type 2 diabetes

The PBS listing of a once-weekly subcutaneous injection of exenatide has been welcomed by a GP diabetes expert. 

The glucagon-like peptide-1 (GLP-1) analogue has already been available on the PBS as a twice-daily subcutaneous injection (Byetta) since 2010.

On Sunday Federal Health Minister Sussan Ley announced the weekly injection (Bydureon) would be available for patients with type 2 diabetes from 1 September.

The drug will be listed as a PBS Authority required (streamlined) benefit for

Latest

Trending